To include your compound in the COVID-19 Resource Center, submit it here.

Resten-NG: Phase II

Interim data from a U.S. Phase II trial in 70 patients showed

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE